INTRODUCTION: Our aim was to evaluate percutaneous treatment of hydatid cyst cases of liver and to evaluate the efficacy, complication rate of percutaneous treatment and the reasons for failure in patients who did not respond to treatment. METHODS: Our study is a retrospective study and percutaneous treatment of hydatid cyst cases of liver was performed in our interventional radiology unit between January 2012 and November 2018 and the patients who were followed up by our clinic were included in the study.
Patients were evaluated in terms of age, sex, localization of the cyst in the liver, number of cysts treated, cyst types and cyst size. Our unsuccessful treatment criteria are; increased cyst size without septation-calcification, no change in cyst stage, extravasation and recurrence.
RESULTS: In our study, a total of 119 percutaneous treatment was applied to 104 patients [38 (36.5%) males and 66 (63.5%) females]. The percutaneous cysts were 4-16 cm in diameter and the average diameter was 7.8 cm. Ninety two (77%) cysts were compatible with type 1, 25 (21%) type 2 and 2 (1.6%) type 3 cyst hydatid.
One hundred one treatment (85%) were successful; 18 treatment (15%) were not successful. Five (28%) of the unsuccessful treatment had cystobiliary fistulization, 2 (11%) had extravasation, 3 (17%) had inadequate medical treatment and 8 (44%) had recurrence.
DISCUSSION AND CONCLUSION: Percutaneous treatment in hydatid cyst is a highly effective method because of can be applied in more than one cyst in the same session and low complication rate
